Standout Papers

Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non–Small-Cell... 2011 2026 2016 2021 694
  1. Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non–Small-Cell Lung Cancer (2011)
    Matthew Krebs, Robert Szczepaniak‐Sloane et al. Journal of Clinical Oncology
  2. Clinical Significance and Molecular Characteristics of Circulating Tumor Cells and Circulating Tumor Microemboli in Patients With Small-Cell Lung Cancer (2012)
    Matthew Krebs, Lee Lancashire et al. Journal of Clinical Oncology
  3. Molecular analysis of circulating tumour cells—biology and biomarkers (2014)
    Matthew Krebs, Robert Metcalf et al. Nature Reviews Clinical Oncology

Immediate Impact

1 by Nobel laureates 36 from Science/Nature 96 standout
Sub-graph 1 of 21

Citing Papers

Palliative Care for Patients With Cancer: ASCO Guideline Update
2024 Standout
Adagrasib in Advanced Solid Tumors Harboring aKRASG12CMutation
2023 Standout

Works of Matthew Krebs being referenced

459MO Phase Ia study to evaluate GDC-6036 monotherapy in patients with solid tumors with a KRAS G12C mutation
2022
Phase I cancer trials: a qualitative study of specialist palliative care
2019

Author Peers

Author Last Decade Papers Cites
Matthew Krebs 3876 1786 2127 151 5.3k
Brigitte Rack 4501 1496 3612 214 6.4k
Marius Ilié 3269 2305 2343 162 5.8k
Edwin M. Posadas 1865 1842 1842 169 5.4k
Michail Ignatiadis 3698 1491 3734 126 6.4k
François‐Clément Bidard 4884 2301 4437 216 7.5k
Daniel Shao-Weng Tan 2477 1976 1016 171 4.7k
Frederik Marmé 4106 1092 2603 227 6.3k
Daniel C. Danila 2468 3886 2796 128 6.5k
Johannes H.A.M. Kaanders 1698 2197 2434 174 7.3k
Peter Vermeulen 3098 1109 2651 137 6.4k

All Works

Loading papers...

Rankless by CCL
2026